Investor Relations

co.don AG stands for open, dependable communications with shareholders,  financial analysts and media. By providing transparent, timely information we create a positive foundation for developing a trusted relationship with the financial community.

Why not find out about our company's rapid development and ambitious targets? As a shareholder you too will benefit from the positive long-term  performance of our market capitalisation.

We are happy to answer your questions on our corporate development and can provide you with further relevant information.

24 July 2017: CO.DON share: WARBURG RESEARCH GmbH confirms buy recommendation and increases target price for CO.DON share

The Hamburg-based equity research company WARBURG RESEARCH GmbH has confirmed its buy recommendation and increased the target price from € 11,32 up to € 13,50 per share following the announcement of the EU approval for the articular cartilage product of the company. 

 

The full update to the research study is available here 

19 May 2017: CO.DON share: SPHENE CAPITAL GmbH confirms buy recommendation and increases target price for CO.DON share

The Munich-based Research Company SPHENE CAPITAL GmbH has renewed its purchase recommendation and increased the price target following the announcement of the "positive opinion" by the CHMP in connection with the EU approval application for the articular cartilage product of the company. Within 12 to 24 months, the analysts see a price target of EUR 7.50 per share.

 

The full update to the research study (German Language) is available here